Status:
COMPLETED
Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia
Lead Sponsor:
Pfizer
Conditions:
Pneumonia
Eligibility:
All Genders
18-90 years
Brief Summary
The purpose of this non-interventional, retrospective study of existing data is to evaluate clinical outcomes related to Methicillin-resistant Staphylococcus aureus hospital based pneumonia by treatme...
Detailed Description
All patients meeting inclusion/exclusion criteria from inpatient database from 1/1/02-9/30/10.
Eligibility Criteria
Inclusion
- MRSA and pneumonia cases by ICD-9 code identification.
- Diagnosis included during inpatient stay.
- Treatment initiation in hospital.
Exclusion
- Death of discharge within 3 days of treatment initiation.
- Exposure to other treatments with MRSA activity.
Key Trial Info
Start Date :
December 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
5271 Patients enrolled
Trial Details
Trial ID
NCT01819935
Start Date
December 1 2012
End Date
January 1 2013
Last Update
January 30 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.